Global Hormone Replacement Therapy Market | Share, Size

1
The Global Hormone Replacement Therapy Market to
Soar at CAGR of 7.75 by 2028
Triton Market Research presents the Global
Hormone Replacement Therapy Market segmented by
Type of Disease (Hypothyroidism, Menopause,
Growth Hormone Deficiency, Male Hypogonadism,
Other Type of Diseases), Route of Administration
(Transdermal, Oral, Parenteral, Other Routes of
Administration), Therapy Type (Testosterone
Hormone Replacement Therapy, Progestogen Hormone
Replacement Therapy, Estrogen Hormone
Replacement Therapy, Human Growth Hormone
Replacement Therapy, Thyroid Hormone Replacement
Therapy), and Geography (Middle East and Africa,
Latin America, Europe, Asia-Pacific, North
America). It further discusses the Market
Summary, Industry Outlook, Impact of COVID-19,
Key Insights, Porters Five Forces Model, Market
Attractiveness Index, Vendor Scorecard, Key
Strategic Developments, Drivers, Restraints,
Opportunities, Competitive Landscape, Research
Methodology Scope, Global Market Size,
Forecasts Analysis (2021-2028). Triton Market
Researchs report alludes that the global hormone
replacement therapy market is envisioned to
experience growth in value at a CAGR of 7.75
over the period 2021-2028.
Request a Free Sample https//www.tritonmarketres
earch.com/reports/hormone-replacement-therapy-mark
etrequest-free- sample Hormone replacement
therapy refers to a procedure that helps relieve
symptoms of menopause, hypothyroidism, and
growth hormone deficiency. It replaces hormones,
such as thyroid, progestogen, and testosterone,
among others.
2
Factors such as the availability of alternative
therapy and the launch of telemedicine clinical
practice services are creating novel
opportunities for the hormone replacement therapy
market over the projected period. Around three
in four women seeking treatment for menopausal
symptoms fail to receive the necessary treatment
due to the lack of healthcare professionals with
midlife health expertise. In such a scenario,
CurieMS launched its first telemedicine platform
offering expert consultation and delivering
home-based hormone replacement therapies.
However, the high cost of treatment and adverse
reactions associated with the treatment
negatively impacts the overall growth of the
hormone replacement therapy market. Globally,
North America holds the largest market for
hormone replacement therapy market and is
anticipated to continue to have its hold on the
market over the registered period. The regions
strong growth can be credited to the
well-developed healthcare system, coupled with
the enactment of proper regulations associated
with the hormone. Furthermore, the development of
new drugs, innovations for human growth hormone
therapy, and testosterone therapy are another set
of factors offering beneficial opportunities to
the hormone replacement market in North
America. The leading companies in the hormone
replacement therapy market are Eli Lilly
Company, Ipsen, Abbott Laboratories, Genentech
Inc, Noven Pharmaceuticals Inc, Viatris Inc
(Mylan NV), Pfizer Inc, Teva Pharmaceutical
Industries Ltd, Novartis AG, Merck KGAA, Amgen,
Dr Reddys Laboratories Ltd, ANI
Pharmaceuticals, Bayer AG, and Novo Nordisk
A/S. Several leading players are engaged in
aggressive marketing campaigns, which is
increasing the competition levels within the
market. This increase has led to a surge in
strategic collaborations among existing market
players. For instance, Pfizer acquired Wyeth to
expand its share in estrogen replacement
therapy. Hence, this indicates the competition to
be relatively intense in the upcoming
years. Contact Us sales_at_tritonmarketresearch.com
Phone [phone]